"10.1371_journal.pone.0082867","plos one","2013-12-30T00:00:00Z","Carmen Parola; Laura Salogni; Xenia Vaira; Sara Scutera; Paolo Somma; Valentina Salvi; Tiziana Musso; Giuseppe Tabbia; Marco Bardessono; Christian Pasquali; Alberto Mantovani; Silvano Sozzani; Daniela Bosisio","Dept. Molecular and Translational Medicine, Università degli Studi di Brescia, Brescia, Italy; Dept. Public Health and Pediatric Sciences, Università degli Studi di Torino, Torino, Italy; Pulmonary Division, Ospedale S. Giovanni Battista, Torino, Italy; Preclinical Research, OM Pharma SA, Meyrin 2/Geneva, Switzerland; Humanitas Clinical and Research Center, Rozzano, Italy; Dept. Biotechnology and Translational Medicine, Università degli Studi di Milano, Milano, Italy","Conceived and designed the experiments: DB AM SS. Performed the experiments: C. Parola LS XV SC PS VS TM. Analyzed the data: C. Parola LS PS VS TM DB. Contributed reagents/materials/analysis tools: GT MB C. Pasquali. Wrote the paper: SS DB.","The authors have read the journals policy and have the following financial conflict: this work was partially funded by Viforpharma, who initially took part in general research planning. The authors also declare that one of the authors, namely Dr. Christian Pasquali, is affiliated to OM Pharma SA, the commercial company that produces and sells OM-85. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","12","Carmen Parola","CP",13,TRUE,3,1,1,2,TRUE,TRUE,TRUE,5,"2;3;5;6;7",TRUE
